These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 27976925)
1. Previvors' Uncertainty Management Strategies for Hereditary Breast and Ovarian Cancer. Dean M; Davidson LG Health Commun; 2018 Feb; 33(2):122-130. PubMed ID: 27976925 [TBL] [Abstract][Full Text] [Related]
2. "When information is not enough": A model for understanding BRCA-positive previvors' information needs regarding hereditary breast and ovarian cancer risk. Dean M; Scherr CL; Clements M; Koruo R; Martinez J; Ross A Patient Educ Couns; 2017 Sep; 100(9):1738-1743. PubMed ID: 28385363 [TBL] [Abstract][Full Text] [Related]
3. "It's not if I get cancer, it's when I get cancer": BRCA-positive patients' (un)certain health experiences regarding hereditary breast and ovarian cancer risk. Dean M Soc Sci Med; 2016 Aug; 163():21-7. PubMed ID: 27376595 [TBL] [Abstract][Full Text] [Related]
4. "It was an Emotional Baby": Previvors' Family Planning Decision-Making Styles about Hereditary Breast and Ovarian Cancer Risk. Dean M; Rauscher EA J Genet Couns; 2017 Dec; 26(6):1301-1313. PubMed ID: 28138923 [TBL] [Abstract][Full Text] [Related]
5. "Take your time, then follow your heart:" Previvors' advice for communicating about family planning after testing positive for a BRCA genetic variant. Rauscher EA; Dean M Fam Syst Health; 2017 Dec; 35(4):486-497. PubMed ID: 29283615 [TBL] [Abstract][Full Text] [Related]
6. The Boumis JK; Dean M Health Commun; 2024 Sep; 39(10):1942-1954. PubMed ID: 37622341 [No Abstract] [Full Text] [Related]
7. Cancer risk management decision making for BRCA+ women. Leonarczyk TJ; Mawn BE West J Nurs Res; 2015 Jan; 37(1):66-84. PubMed ID: 24470135 [TBL] [Abstract][Full Text] [Related]
8. "Where do I go? Who do I go to?": BRCA Previvors, genetic counselors and family planning. Wellman ML; Holton AE; Kaphingst KA PEC Innov; 2023 Dec; 2():100157. PubMed ID: 37214521 [TBL] [Abstract][Full Text] [Related]
9. Differences between women who pursued genetic testing for hereditary breast and ovarian cancer and their at-risk relatives who did not. Katapodi MC; Northouse L; Pierce P; Milliron KJ; Liu G; Merajver SD Oncol Nurs Forum; 2011 Sep; 38(5):572-81. PubMed ID: 21875844 [TBL] [Abstract][Full Text] [Related]
10. Previvorship Posting: Why Breast Cancer Previvors Share Their Stories on Social Media. Wellman ML; Holton AE; Kaphingst KA Health Commun; 2023 Oct; 38(11):2441-2449. PubMed ID: 35582752 [TBL] [Abstract][Full Text] [Related]
11. Maximising survival: the main concern of women with hereditary breast and ovarian cancer who undergo genetic testing for BRCA1/2. Jeffers L; Morrison PJ; McCaughan E; Fitzsimons D Eur J Oncol Nurs; 2014 Aug; 18(4):411-8. PubMed ID: 24731853 [TBL] [Abstract][Full Text] [Related]
12. What Do Breast Cancer Previvors Tell Us About Their Stories? To Know or Not to Know? Uslu Y; Er S; Subaşı Sezgin D; Yeşilyurt A; Uras C Semin Oncol Nurs; 2024 Oct; 40(5):151714. PubMed ID: 39164159 [TBL] [Abstract][Full Text] [Related]
13. BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes. Lerman C; Narod S; Schulman K; Hughes C; Gomez-Caminero A; Bonney G; Gold K; Trock B; Main D; Lynch J; Fulmore C; Snyder C; Lemon SJ; Conway T; Tonin P; Lenoir G; Lynch H JAMA; 1996 Jun; 275(24):1885-92. PubMed ID: 8648868 [TBL] [Abstract][Full Text] [Related]
14. Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool. Rupert DJ; Squiers LB; Renaud JM; Whitehead NS; Osborn RJ; Furberg RD; Squire CM; Tzeng JP Patient Educ Couns; 2013 Aug; 92(2):188-96. PubMed ID: 23664232 [TBL] [Abstract][Full Text] [Related]
15. Toward a new understanding of risk perception among young female BRCA1/2 "previvors". Hoskins LM; Roy KM; Greene MH Fam Syst Health; 2012 Mar; 30(1):32-46. PubMed ID: 22429077 [TBL] [Abstract][Full Text] [Related]
16. "It was a no-brainer": A qualitative study of factors driving previvors' decision-making when considering risk-reducing salpingectomy with delayed oophorectomy. Gellman C; Ezratty C; Schwarz J; Kolev V; Blank SV Gynecol Oncol Rep; 2022 Apr; 40():100948. PubMed ID: 35265744 [TBL] [Abstract][Full Text] [Related]
17. Knowledge of risk management strategies, and information and risk management preferences of women at increased risk for ovarian cancer. Tiller K; Meiser B; Gould L; Tucker K; Dudding T; Franklin J; Friedlander M; Andrews L Psychooncology; 2005 Apr; 14(4):249-61. PubMed ID: 15386771 [TBL] [Abstract][Full Text] [Related]
18. Hereditary breast and ovarian cancer: research on how women respond to genetic testing. Bingham R Nurs Womens Health; 2012; 16(4):319-24. PubMed ID: 22900808 [TBL] [Abstract][Full Text] [Related]
19. Decision-making on preimplantation genetic diagnosis and prenatal diagnosis: a challenge for couples with hereditary breast and ovarian cancer. Derks-Smeets IA; Gietel-Habets JJ; Tibben A; Tjan-Heijnen VC; Meijer-Hoogeveen M; Geraedts JP; van Golde R; Gomez-Garcia E; van den Bogaart E; van Hooijdonk M; de Die-Smulders CE; van Osch LA Hum Reprod; 2014 May; 29(5):1103-12. PubMed ID: 24603131 [TBL] [Abstract][Full Text] [Related]
20. Psychosocial barriers and facilitators for cascade genetic testing in hereditary breast and ovarian cancer: a scoping review. Afaya A; Kim SW; Park HS; Lim MC; Jung MS; Nam EJ; Park JS; Jeong J; Ryu JM; Kim J; Kim J; Kim M; Jin J; Han J; Kim SY; Park SY; Katapodi MC; Kim S; Fam Cancer; 2024 Jun; 23(2):121-132. PubMed ID: 38662264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]